in isotonic saline) instilled into the conjunctival sac, the contralateral eye in each case serving as a control. Readings with the tonometer (5-5 g. wt.) were made on both eyes at fairly frequent intervals from 30 minutes before until 30 minutes after instilling the mustine HCI. At the end ofthe experiment both animals were killed and the aqueous removed for examination. Each eye was then connected to a saline reservoir and manometer by means of polythene tubing and a No. 15 hypodermic needle inserted into the anterior chamber along the track of the needle used to remove the aqueous. By altering the height of the reservoir above the eye, the Schi6tz tonometer was calibrated for known values of intra-ocular pressure, a stopcock between the eye and the reservoir being closed whilst tonometer readings were taken. The aqueous was tested for protein with 5 per cent. trichloro-acetic acid.
In other animals mustine HCI was instilled into the conjunctival sac some 20 minutes before administering the PPP in order to determine whether this treatment would depress an already increased I.O.P.
Direct Recording of I.O.P. Animals were anaesthetized with urethane as before and a polythene cannula for recording the arterial blood pressure tied in the femoral artery. A fine cannula, through which PPP solution could be infused, was inserted into one lingual artery (Cole, 1959) . The rabbit was turned back uppermost and its head supported on a chin rest some 2 inches above the level of the table. The I.O.P. in both eyes was measured by means of two pressure transducers (Model 267B Sanborn Co., Inc., Waltham, Mass., U.S.A.) connected with the aqueous in the anterior chamber by fine polythene tubing containing heparinized saline (1,000 I.U. per 100 mil.) and terminating in No. 27 hypodermic needles. Before insertion through the cornea each needle was carefully positioned so as to ensure the least possible traction upon the eye. A pressure reservoir, also containing heparinized saline, connected to both the transducer and the intra-ocular needle was raised to 18-20 mm. Hg and the saline was allowed to flow freely out through the needle. With the superior rectus muscle held firmly in fixation forceps the needle was then inserted through the margin of the cornea in the 12 o'clock position so as to lie in the anterior chamber with its bevel facing outwards. A tap connecting the intra-ocular needle with the pressure reservoir was closed and the I.O.P. recording commenced. A precisely similar operation was carried out upon the other eye and the blood-pressure cannula was connected to a third transducer by means of polythene tubing.
The two I.O.P. transducers were connected with two Sanborn preamplifiers (Model 150-1100), and the blood-pressure transducer with a Sanborn Model 150-3000 pre-amplifier, and thence to three of the four channels of a Model 154-100B Sanborn Recorder.
Once steady records for blood and intra-ocular pressure had been obtained, PPP was infused at 0 4 mg/min. through the lingual artery cannula by means of a motor-driven syringe. After some 10 to 15 minutes of this infusion a few drops of 200 mg. per cent. mustine HCl in saline were instilled into each eye and the recording was continued for a further 15 to 20 minutes. In some other animals mustine HCl was instilled before commencing the intracarotid infusion and the administration of PPP was not started until the I.O.P. had begun to rise.
Paracentesis was simulated by an abrupt fall in I.O.P. which was brought about by lowering the reservoir on each side of zero pressure. The intraocular needle was then connected to this low pressure for some 2 minutes, after which the reservoir was disconnected and the I.O.P. was allowed to rise. It was thus possible to observe the recovery phase in both eyes, one of which was receiving a high concentration of PPP from the infusion through the lingual artery.
Results
The Table shows the changes in I.O.P., as measured with the Schiotz tonometer, in animals treated with mustine HCI and with PPP separately and with mustine HCI after PPP. The protein content of the aqueous is recorded semi-quantitatively over a range of -to + + +. It may be seen that, whilst PPP alone has no significant action, it is effective in preventing the ocular hypertension caused by mustine HCI. The rapid increase in I.O.P. produced by mustine HCI in animals not receiving PPP is shown in Fig. 1 (opposite). When the I.O.P. has been raised by treatment with mustine HCI, treatment with PPP reduces it to within the normal range over a period of 30 to 40 minutes (Fig. 4, opposite) . Discussion PPP caused no significant alteration in the blood-pressure recordings. Hence, when attempting to explain the action of PPP upon the I.O.P., the occurrence of changes in systemic B.P. may be discounted both in these experiments and in those in which the Schiotz tonometer was used. This lack of effect on blood pressure is in keeping with other reports of the low toxicity of PPP (Fries, 1956; 1960) .
It is known that, after the blood-aqueous barrier has been damaged by paracentesis, the anterior chamber becomes filled with fluid of high protein content, formed by exudation from the capillaries of the anterior uvea, notably those of the ciliary body (Seidel, 1918; Franceschetti and Wieland, 1928; Poos, 1931; Rohen, 1953) . This increased capillary permeability facilitates the more rapid entry of fluid into the eye and also leads to the inflow channels becoming obstructed by clot formation in the secondary aqueous humour (Zwiauer, Bornschein, and Deutsch, 1951) . The doses of PPP used in the experiments described above are comparable with those which have been shown to prevent increased capillary permeability in response to trauma in other regions (Fries, 1960) and it seems highly probable that its present action was similar. In these experiments if the PPP treatment prevented exudation into the eye, obstruction of the drainage channels by fibrin would be precluded.
The hypertensive action of mustine HCl is likewise dependent upon increased permeability of the blood-aqueous barrier (Davson and Huber, 1950; Davson and Matchett, 1953) which the present results show to be effectively prevented by PPP ( Fig. 1; Table) . This again must be due to prevention of the increase of the permeability of the barrier, since aqueous from eyes treated with mustine HCI and PPP contained very much less protein than that from eyes treated with mustine HC1 only (Table) . When PPP was administered after the barrier had been damaged by mustine HCI and the increase in I.O.P. had begun, this rise was arrested or reversed ( Figs 3 and 4) , a finding which indicates that the aqueous drainage remained adequate. PPP given alone did not lower the I.O.P. in normal (untreated) eyes and there is, therefore, no reason to suppose that it increases facility of outflow or diminishes inflow unless the barrier is abnormally permeable.
In vitro experiments have shown that the outflow resistance may be decreased by adding hyaluronic acid to the fluid perfusing the anterior chamber (Bairany and Scotchbrook, 1954; BiarLany and Woodin, 1955; Fran9ois, Rabaey, and Neetens, 1956) , and in the present experiments one would have anticipated, by virtue of its anti-hyaluronidase activity, that PPP, if it had exerted any action at all on the outflow system, might have favoured a rise in I.O.P. There was no evidence of such an effect in either the damaged or the control eyes, possibly because the high molecular weight of PPP limits its rate of penetration from blood to aqueous.
There is probably no simple relationship between the condition produced by paracentesis or mustine HCI and the protein exudation of anterior uveitis, and the findings of B6hringer (1957) indicate that the ability of the blood-aqueous barrier to secrete ascorbate was diminished by uveitis but not by paracentesis although massive exudation occurred in both conditions. Nevertheless, PPP may have some clinical application in limiting ocular hypertension in so far as this is due to increased permeability of the bloodaqueous barrier.
Summary
The action of polyphloretin phosphate (PPP) upon the ocular hypertension caused by paracentesis and by mustine hydrochloride instilled into the conjunctival sac has been studied in rabbits:
(1) PPP prevents or limits the rise in I.O.P. which normally follows these procedures.
(2) PPP reduces the raised I.O.P. caused by previous administration of mustine.
(3) PPP prevents the rise in the protein concentration of the aqueous which is caused by mustine HCI.
It appears that these effects are due to a reduction of the capillary permeability in the anterior uveal tract of the damaged eye. 
